Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: A randomized, double-blind, placebo-controlled clinical trial
Todd M. Durell, Lenard A. Adler, Dave W. Williams, Ahmed Deldar, James J. McGough, Paul E. Glaser, Richard L. Rubin, Teresa A. Pigott, Elias H. Sarkis, Bethany K. Fox
Dive into the research topics of 'Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: A randomized, double-blind, placebo-controlled clinical trial'. Together they form a unique fingerprint.